WHO WE SERVE

ONE INTELLIGENCE ECOSYSTEM. EVERY LIFE SCIENCES STAKEHOLDER.

HERMS empowers patients and patient communities, governments, healthcare institutions, pharmaceutical and biotechnology companies, medical technology innovators, manufacturers, research organizations, and investors through 25 specialized, AI-powered intelligence solutions.

From scientific discovery to patient access, we transform complexity into intelligence, intelligence into decisions, and decisions into measurable value.

01

PATIENTS & PATIENT COMMUNITIES

Patients are at the center of every HERMS innovation. We advance patient-centered intelligence that supports earlier access to breakthrough therapies, more informed treatment pathways, enhanced medication safety, and equitable access to healthcare innovation.

Faster access to innovationEnhanced patient safetyBetter health outcomes
Family at a hospital bedside with a child patient
02

GOVERNMENTS & REGULATORY AUTHORITIES

Modernize regulatory oversight, optimize public expenditure, strengthen healthcare governance, and accelerate evidence-based national health strategies.

Smarter regulationBudget efficiencyPublic accountability
Global regulatory authorities symposium
03

PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

Accelerate development, regulatory approvals, pricing strategies, reimbursement, market access, safety surveillance, and commercial performance.

Faster market entryRevenue protectionReduced operating costs
Scientists in a laboratory reviewing global data
04

MEDICAL TECHNOLOGY & DIAGNOSTICS COMPANIES

Strengthen technology evaluation, regulatory readiness, evidence generation, product positioning, and commercialization.

Faster adoptionCompetitive differentiationMarket expansion
Automated diagnostics laboratory with robotic systems
05

MANUFACTURERS & SUPPLY CHAIN ORGANIZATIONS

Optimize technology transfer, manufacturing scale-up, quality intelligence, procurement, supply continuity, and industrial localization.

Operational efficiencySupply resilienceManufacturing competitiveness
Biopharmaceutical manufacturing cleanroom with bioreactors
06

RESEARCH INSTITUTIONS & HEALTHCARE INNOVATORS

Translate discoveries in genomics, cell and gene therapies, regenerative medicine, and emerging technologies into evidence-led development pathways.

Scientific translationDevelopment readinessCommercialization potential
Researchers in a genomics laboratory
07

HOSPITALS & HEALTHCARE SYSTEMS

Support clinical governance, patient safety, technology assessment, evidence evaluation, and operational decision-making.

Safer decisionsResource optimizationBetter healthcare delivery
Clinicians reviewing patient care data in a hospital command center
08

INVESTORS, VENTURE CAPITAL & INNOVATION ECOSYSTEMS

Screen emerging technologies, evaluate scientific and commercial risks, assess investment opportunities, and develop scalable innovation portfolios.

Better diligenceInvestment intelligenceRisk-adjusted opportunities
Professionals collaborating around a global impact ecosystem display
09

PROCUREMENT, TENDER & MARKET ACCESS ORGANIZATIONS

Strengthen tender intelligence, procurement planning, pricing evidence, reimbursement strategies, and resource allocation.

Budget optimizationCompetitive tendersSustainable market access
Automated pharmaceutical warehouse with robotic picking and supply chain analytics

For HCPs

For patients

For researchers

ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.